Insider Transactions in Q3 2024 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Dong Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+6.21%
|
-
|
|
Sep 09
2024
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
1,521
-5.69%
|
$19,773
$13.08 P/Share
|
|
Sep 09
2024
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+11.08%
|
-
|
|
Sep 09
2024
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
859
-0.59%
|
$11,167
$13.08 P/Share
|
|
Sep 09
2024
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,666
+1.13%
|
-
|